Annual Total Liabilities
$48.40 M
+$8.38 M+20.92%
December 31, 2023
Summary
- As of February 23, 2025, VRDN annual total liabilities is $48.40 million, with the most recent change of +$8.38 million (+20.92%) on December 31, 2023.
- During the last 3 years, VRDN annual total liabilities has risen by +$37.18 million (+331.47%).
- VRDN annual total liabilities is now at all-time high.
Performance
VRDN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$64.40 M
+$8.08 M+14.34%
September 30, 2024
Summary
- As of February 23, 2025, VRDN quarterly total liabilities is $64.40 million, with the most recent change of +$8.08 million (+14.34%) on September 30, 2024.
- Over the past year, VRDN quarterly total liabilities has stayed the same.
- VRDN quarterly total liabilities is now at all-time high.
Performance
VRDN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VRDN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.9% | 0.0% |
| 3 y3 years | +331.5% | 0.0% |
| 5 y5 years | +227.0% | 0.0% |
VRDN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +202.6% | at high | +302.7% |
| 5 y | 5-year | at high | +331.5% | at high | +474.1% |
| alltime | all time | at high | +2207.1% | at high | +3344.3% |
Viridian Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $64.40 M(+14.3%) |
| Jun 2024 | - | $56.33 M(+17.7%) |
| Mar 2024 | - | $47.85 M(-1.1%) |
| Dec 2023 | $48.40 M(+20.9%) | $48.40 M(+7.1%) |
| Sep 2023 | - | $45.18 M(+26.9%) |
| Jun 2023 | - | $35.61 M(-1.3%) |
| Mar 2023 | - | $36.09 M(-9.8%) |
| Dec 2022 | $40.03 M(+150.3%) | $40.03 M(+26.8%) |
| Sep 2022 | - | $31.57 M(+13.1%) |
| Jun 2022 | - | $27.92 M(+69.0%) |
| Mar 2022 | - | $16.52 M(+3.3%) |
| Dec 2021 | $15.99 M(+42.6%) | $15.99 M(-3.7%) |
| Sep 2021 | - | $16.61 M(-13.9%) |
| Jun 2021 | - | $19.29 M(+14.6%) |
| Mar 2021 | - | $16.83 M(+50.1%) |
| Dec 2020 | $11.22 M(-22.7%) | $11.22 M(-4.9%) |
| Sep 2020 | - | $11.79 M(-4.2%) |
| Jun 2020 | - | $12.31 M(+2.2%) |
| Mar 2020 | - | $12.05 M(-16.9%) |
| Dec 2019 | $14.51 M | $14.51 M(-7.3%) |
| Sep 2019 | - | $15.64 M(+1.9%) |
| Jun 2019 | - | $15.35 M(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $13.99 M(-5.5%) |
| Dec 2018 | $14.80 M(+6.0%) | $14.80 M(-6.5%) |
| Sep 2018 | - | $15.84 M(+11.4%) |
| Jun 2018 | - | $14.22 M(-0.5%) |
| Mar 2018 | - | $14.29 M(+2.3%) |
| Dec 2017 | $13.97 M(+204.7%) | $13.97 M(+72.6%) |
| Sep 2017 | - | $8.10 M(-6.8%) |
| Jun 2017 | - | $8.69 M(-11.3%) |
| Mar 2017 | - | $9.80 M(+113.7%) |
| Dec 2016 | $4.58 M(+84.0%) | $4.58 M(+60.6%) |
| Sep 2016 | - | $2.85 M(+9.6%) |
| Jun 2016 | - | $2.60 M(+6.0%) |
| Mar 2016 | - | $2.46 M(-1.4%) |
| Dec 2015 | $2.49 M(+18.8%) | $2.49 M(+15.2%) |
| Sep 2015 | - | $2.16 M(+0.6%) |
| Jun 2015 | - | $2.15 M(-17.2%) |
| Mar 2015 | - | $2.60 M(+23.8%) |
| Dec 2014 | $2.10 M(-92.4%) | $2.10 M(+5.2%) |
| Sep 2014 | - | $2.00 M(-9.3%) |
| Jun 2014 | - | $2.20 M(+17.6%) |
| Mar 2014 | - | $1.87 M(-93.2%) |
| Dec 2013 | $27.56 M(+13.8%) | $27.56 M |
| Dec 2012 | $24.22 M | - |
FAQ
- What is Viridian Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Viridian Therapeutics?
- What is Viridian Therapeutics annual total liabilities year-on-year change?
- What is Viridian Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly total liabilities year-on-year change?
What is Viridian Therapeutics annual total liabilities?
The current annual total liabilities of VRDN is $48.40 M
What is the all time high annual total liabilities for Viridian Therapeutics?
Viridian Therapeutics all-time high annual total liabilities is $48.40 M
What is Viridian Therapeutics annual total liabilities year-on-year change?
Over the past year, VRDN annual total liabilities has changed by +$8.38 M (+20.92%)
What is Viridian Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VRDN is $64.40 M
What is the all time high quarterly total liabilities for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly total liabilities is $64.40 M
What is Viridian Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VRDN quarterly total liabilities has changed by $0.00 (0.00%)